Dominic Borie

2.5k total citations · 2 hit papers
46 papers, 1.0k citations indexed

About

Dominic Borie is a scholar working on Oncology, Immunology and Neurology. According to data from OpenAlex, Dominic Borie has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 16 papers in Immunology and 7 papers in Neurology. Recurrent topics in Dominic Borie's work include CAR-T cell therapy research (13 papers), Cytokine Signaling Pathways and Interactions (9 papers) and Pharmacological Effects of Natural Compounds (7 papers). Dominic Borie is often cited by papers focused on CAR-T cell therapy research (13 papers), Cytokine Signaling Pathways and Interactions (9 papers) and Pharmacological Effects of Natural Compounds (7 papers). Dominic Borie collaborates with scholars based in United States, Germany and Switzerland. Dominic Borie's co-authors include Paul S. Changelian, John J. O’Shea, Marko Pesu, Bruce A. Reitz, Ming‐Sing Si, Mona G. Flores, Randall E. Morris, Andrew Campbell, Ricardo Paniagua and James N. Kochenderfer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and Blood.

In The Last Decade

Dominic Borie

41 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

2024 78 citations Johanna Richter, Boris Fehse et al. Med profile →
Chimeric antigen receptor T cell therapy for autoimmune disease

2024 52 citations James Chung, Jennifer N. Brudno et al. Nature reviews. Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dominic Borie United States	17	534	434	207	124	123	46	1.0k
Patrizia Mella Italy	18	281 0.5×	553 1.3×	238 1.1×	23 0.2×	37 0.3×	29	1.2k
Momoko Nishikori Japan	20	906 1.7×	566 1.3×	335 1.6×	66 0.5×	31 0.3×	99	1.7k
Irena Frydecka Poland	24	488 0.9×	939 2.2×	210 1.0×	62 0.5×	22 0.2×	103	1.5k
Satoshi Kojo Japan	23	409 0.8×	1.5k 3.5×	335 1.6×	50 0.4×	32 0.3×	38	2.0k
Kesley Attridge United Kingdom	9	739 1.4×	1.4k 3.3×	183 0.9×	50 0.4×	40 0.3×	12	1.8k
Tiago R. Matos United States	16	271 0.5×	1.0k 2.3×	185 0.9×	51 0.4×	25 0.2×	32	1.5k
Soi Cheng Law Australia	12	203 0.4×	598 1.4×	222 1.1×	326 2.6×	11 0.1×	27	1.1k
Chung-Che Chang United States	18	529 1.0×	236 0.5×	231 1.1×	68 0.5×	37 0.3×	49	1.0k
Jason Foley United States	17	482 0.9×	922 2.1×	280 1.4×	20 0.2×	33 0.3×	24	1.4k

Countries citing papers authored by Dominic Borie

Since Specialization

Citations

This map shows the geographic impact of Dominic Borie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominic Borie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominic Borie more than expected).

Fields of papers citing papers by Dominic Borie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominic Borie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominic Borie. The network helps show where Dominic Borie may publish in the future.

Co-authorship network of co-authors of Dominic Borie

This figure shows the co-authorship network connecting the top 25 collaborators of Dominic Borie. A scholar is included among the top collaborators of Dominic Borie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominic Borie. Dominic Borie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aloizou, Athina‐Maria, Christoph H. Lohmann, Simon Faissner, et al.. (2025). Anti-CD19 CAR T-Cell Therapy in Advanced Stiff-Person Syndrome and Concomitant Myasthenia Gravis. Neurology Neuroimmunology & Neuroinflammation. 12(6). e200479–e200479. 1 indexed citations

Keitel, Verena, Michael C. Kreißl, Tobias Goetze, et al.. (2025). CAR T-cell therapy induces remission in multiorgan IgG4-related disease with hepatobiliary involvement. Journal of Hepatology. 84(4). 829–836.

Haase, Isabell, Boris Fehse, Nikolas Ruffer, et al.. (2025). A novel approach to refractory idiopathic inflammatory myopathy: CD19 CAR T-cell therapy—case report and literature review. Lara D. Veeken. 64(9). 5101–5107. 1 indexed citations

Gerber, Jonathan M., Ehsan Dehdashtian, Guangnan Hu, et al.. (2025). Successful autologous CD19 CAR T cell therapy following severe lupus flare during immunosuppressive washout in refractory lupus nephritis. Lupus Science & Medicine. 12(2). e001742–e001742.

Faissner, Simon, Jeremias Motte, Christian Geis, et al.. (2024). Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome. Proceedings of the National Academy of Sciences. 121(26). e2403227121–e2403227121. 25 indexed citations

Richter, Johanna, Boris Fehse, Stefanie Reinhardt, et al.. (2024). CD19-Directed CAR T Cell Therapy in 4 Patients with Refractory Multiple Sclerosis. Blood. 144(Supplement 1). 2073–2073. 1 indexed citations

Wickel, Jonathan, Ulf Schnetzke, Jenny Rinke, et al.. (2024). Anti-CD19 CAR-T cells are effective in severe idiopathic Lambert-Eaton myasthenic syndrome. Cell Reports Medicine. 5(11). 101794–101794. 5 indexed citations

Richter, Johanna, Boris Fehse, Stefanie Reinhardt, et al.. (2024). CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med. 5(6). 550–558.e2. 78 indexed citations breakdown →

Chung, James, Jennifer N. Brudno, Dominic Borie, & James N. Kochenderfer. (2024). Chimeric antigen receptor T cell therapy for autoimmune disease. Nature reviews. Immunology. 24(11). 830–845. 52 indexed citations breakdown →

10.

Park, Sungha, et al.. (2023). POS0007 KYV-101, A FULLY HUMAN CD19 CAR T CELL GENERATED FROM AUTOIMMUNE PATIENT LYMPHOCYTES, DEMONSTRATES CAR-MEDIATED AND CD19-DEPENDENT ACTIVITY AGAINST AUTOLOGOUS B CELLS. Annals of the Rheumatic Diseases. 82. 208–209. 2 indexed citations

11.

Li, Hong, Kathleen Köck, William A. Rees, et al.. (2014). Prediction of clinical pharmacokinetics of AMG 181, a human anti‐α₄β₇ monoclonal antibody for treating inflammatory bowel diseases. Pharmacology Research & Perspectives. 3(1). e00098–e00098. 14 indexed citations

12.

Si, Ming‐Sing, Gerald J. Berry, Mona G. Flores, et al.. (2006). Janus kinase 3 inhibition with CP-690,550 prevents allograft vasculopathy. Transplant International. 19(12). 1014–1021. 29 indexed citations

13.

Gregory, Clare R., Donald V. Cramer, Insiyyah Patanwala, et al.. (2006). Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes. BMC Immunology. 7(1). 3–3. 12 indexed citations

14.

Si, Ming‐Sing, Bruce A. Reitz, & Dominic Borie. (2005). Effects of the kinase inhibitor CGP41251 (PKC 412) on lymphocyte activation and TNF-α production. International Immunopharmacology. 5(7-8). 1141–1149. 8 indexed citations

15.

Stalder, Mario, Tudor Bı̂rsan, Bernard Hausen, Dominic Borie, & Randall E. Morris. (2005). Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy. Transplant International. 18(10). 1158–1165. 11 indexed citations

16.

Kleihauer, Annette, Clare R. Gregory, Dominic Borie, et al.. (2005). Identification of the V_H genes encoding xenoantibodies in non‐immunosuppressed rhesus monkeys. Immunology. 116(1). 89–102. 9 indexed citations

17.

Paniagua, Ricardo, Andrew Campbell, Paul S. Changelian, et al.. (2005). Quantitative Analysis of the Immunosuppressant CP-690,550 in Whole Blood by Column-Switching High-Performance Liquid Chromatography and Mass Spectrometry Detection. Therapeutic Drug Monitoring. 27(5). 608–616. 11 indexed citations

18.

Flores, Mona G., Bari Holm, Michael J. Larson, et al.. (2004). A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies. Journal of Surgical Research. 124(2). 280–288. 1 indexed citations

19.

Gregory, Clare R., Andrew E. Kyles, Lynda Bernsteen, et al.. (2004). Compared with Cyclosporine, ISATX247 Significantly Prolongs Renal-Allograft Survival in a Nonhuman Primate Model. Transplantation. 78(5). 681–685. 20 indexed citations

20.

Borie, Dominic, John J. O’Shea, & Paul S. Changelian. (2004). JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants. Trends in Molecular Medicine. 10(11). 532–541. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact